2012
DOI: 10.1016/j.clp.2012.06.009
|View full text |Cite
|
Sign up to set email alerts
|

Cell-Based Strategies to Reconstitute Lung Function in Infants with Severe Bronchopulmonary Dysplasia

Abstract: Recent advances in our understanding of stem/progenitor cells and their potential to repair damaged organs offer the possibility of cell-based treatments for neonatal lung injury. This review summarizes basic concepts of stem/progenitor cell biology and discusses the recent advances and challenges of cell-based therapies for lung diseases, with a particular focus on bronchopulmonary dysplasia (BPD), a form of chronic lung disease that primarily affects very preterm infants. Despite advances in perinatal care, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

2013
2013
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(17 citation statements)
references
References 114 publications
(99 reference statements)
0
17
0
Order By: Relevance
“…A number of putative resident progenitor cells have been identified in the lung, including proximal airway, distal lung epithelial, lung mesenchymal, and lung endothelial progenitor cells. Numerous experimental and clinical studies have tested the efficacy of these cell-based therapies in promoting lung regeneration after injury (comprehensively reviewed in [78]). Further, in a landmark report, Petersen et al successfully engineered rat lungs ex vivo using a decellularized lung extracellular matrix entirely repopulated with neonatal rat epithelial and endothelial cells, that functioned for a short time when implanted in rats in vivo [79].…”
Section: Overview Of Lung Developmentmentioning
confidence: 99%
“…A number of putative resident progenitor cells have been identified in the lung, including proximal airway, distal lung epithelial, lung mesenchymal, and lung endothelial progenitor cells. Numerous experimental and clinical studies have tested the efficacy of these cell-based therapies in promoting lung regeneration after injury (comprehensively reviewed in [78]). Further, in a landmark report, Petersen et al successfully engineered rat lungs ex vivo using a decellularized lung extracellular matrix entirely repopulated with neonatal rat epithelial and endothelial cells, that functioned for a short time when implanted in rats in vivo [79].…”
Section: Overview Of Lung Developmentmentioning
confidence: 99%
“…Recent animal and human studies suggest that damage or depletion of epithelial and/or vascular stem cells in the developing lung likely contributes to the pathogenesis of BPD (75). For instance, hyperoxia-induced BPD in neonatal rats is associated with decreased circulating and resident mesenchymal stem cells (MSC) (76).…”
Section: Experimental Therapiesmentioning
confidence: 99%
“…Bone marrow derived stem cells, mesenchymal stem cells or marrow stromal cells (MSCs) have demonstrated great promise in regenerative medicine for multiple organs including the lungs1. Although MSCs therapy showed beneficial effects in the treatment of injured tissue, their mechanisms of action are still being investigated.…”
mentioning
confidence: 99%